Apellis Pharmaceuticals · 2 months ago
Executive Director, Field Medical Affairs
Waltham, Massachusetts, United States
Full-time
Hybrid
Director/Executive
10+ years expApellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. The Executive Director of Field Medical Affairs is responsible for defining and driving the US field medical strategy across therapeutic areas, overseeing engagement with healthcare providers, and leading the field medical teams to ensure operational effectiveness and scientific excellence.
BiotechnologyHealth CarePharmaceuticalTherapeutics
Responsibilities
Develop and lead the US field Medical Affairs strategy, ensuring alignment with global medical, clinical, and commercialization priorities
Build and evolve scalable field engagement models and infrastructure to support current and future launch readiness and enable high performing field medical teams
Provide strategic and operational leadership to senior field medical leaders ensuring aligned execution across all US field teams including both the MSL field team and the Medical Value Liaison (MVL) team
Foster a culture of performance, development, and scientific excellence across all field medical teams
Collaborate with global Medical Affairs counterparts to align field strategies and ensure consistency in scientific exchange and insight integration
Oversee field medical excellence, ensuring consistency in engagement quality, insight capture, training, and metrics across therapeutic areas
Partner with therapeutic area leads to develop and implement national and regional KOL and stakeholder engagement strategies
Coach, mentor, and support senior field leaders to drive team development, performance management, and retention of top talent
Establish a robust process for insight generation, synthesis, and dissemination to inform clinical development, market access and medical strategies
Collaborate cross-functionally to strategically deploy and support field teams while ensuring compliance and alignment with organizational objectives
Qualification
Required
Advanced degree (PhD, Pharm D, MD or equivalent)
10+ years of progressive leadership in Medical Affairs including significant field-based experience across multiple therapeutic areas
Proven track record building and optimizing field medical engagement models including experience supporting product launches and lifecycle management
Demonstrated success in leading large, diverse field organizations and managing senior leaders with a focus on talent development, succession planning, and strategic execution
Excellent communication, presentation, and stakeholder management skills with an ability to influence across levels and functions
Thrives in fast-paced, evolving environments; biotech experience preferred
Travel up to 50% required
Preferred
Expertise in ophthalmology strongly preferred; additional expertise in rare disease, hematology, nephrology is preferred
Benefits
401(k) plan with company match
Inclusive family building benefits
Flexible time off
Summer and winter shutdowns
Paid family leave
Disability and life insurance
And more!
Company
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
501-1000 employees
H1B Sponsorship
Apellis Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (11)
2024 (6)
2023 (6)
2022 (8)
2021 (7)
2020 (3)
Funding
Current Stage
Public CompanyTotal Funding
$919.6MKey Investors
Swedish Orphan BiovitrumSixth StreetNorthern Star Partners
2025-06-01Post Ipo Debt· $275M
2024-05-14Post Ipo Debt· $475M
2022-04-14Post Ipo Equity· $1.07M
Leadership Team
Cedric Francois
Co-Founder and CEO
Caroline Baumal
Chief Medical Officer
Recent News
2026-01-18
Investor's Business Daily
2026-01-13
Company data provided by crunchbase